Affichage 1 à 2 des 2 essais cliniques
|
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
|---|---|---|---|
|
(EN) Pelvic Nodes Ultra-Hypo Fractionated Versus Conventionally Fractionated IMRT With HDR Brachytherapy Boost in Prostate Cancer: A Collaborative Multi-institutional Non-inferiority Phase 3 Trial.
PCS-XI NCT05820633  Actif en recrutement
|
CISSS DE L'OUTAOUAIS
HOPITAL DE GATINEAU
|
Prostate |
Dr Pierre-Yves McLaughlin Céline Roy 819-966-6100 poste 3669 |
|
(EN) A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared With Placebo Plus ADT in Patients With High-risk Biochemical Recurrence (BCR) of Prostate Cancer
ARASTEP NCT05794906 Actif en recrutement
|
CISSS DE L'OUTAOUAIS
HOPITAL DE GATINEAU
|
Prostate |
Dr Steven Tisseverasinghe Céline Roy 819-966-6100 poste 3669 |
Groupe d'étude en oncologie du Québec